Murine immunosuppression with mycoviral dsRNA

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Mycoviral double-stranded RNA (dsRNA) has been investigated for its biological activities.
• Understanding the immunomodulatory effects of dsRNA is crucial for developing novel therapeutics.

Purpose of the Study:

• To investigate the impact of different molecular weight mycoviral dsRNA species on the immune response in a mouse model.
• To determine the dose-dependent immunosuppressive effects of mycoviral dsRNA.

Main Methods:

• Three distinct molecular weight species of mycoviral dsRNA were isolated using electrophoresis.
• C57Bl/6 mice were immunized with sheep red blood cells (sRBC) and varying doses of dsRNA.
• Hemolytic antibody titers and hemagglutination titers were measured to assess the immune response.

Main Results:

• All tested mycoviral dsRNA species significantly suppressed the primary hemolytic antibody titer against sRBC (p < 0.0001).
• Immunosuppression was observed 8 days post-immunization with approximately 15 micrograms of dsRNA per mouse.
• No significant immune suppression was detected upon secondary sRBC immunization 60 days later, indicating a typical secondary antibody response.

Conclusions:

• Mycoviral dsRNA species with molecular weights ranging from 1.0 x 10(6) to 3.5 x 10(6) daltons are potent immunosuppressors.
• A dose of approximately 15 micrograms of dsRNA per mouse effectively suppressed the primary immune response.
• The immunosuppressive effect appears to be transient, with no impact on the secondary immune response.